OCT-based Machine Learning FFR for Predicting Post-PCI FFR

Status Not yet recruiting

Clinical Trial Summary

This study aims to compare the diagnostic accuracy of the fractional flow reserve (FFR) model derived by machine learning based on optical coherence tomography (OCT) exam after coronary artery stent implantation with the wire-based FFR.

Clinical Trial Description

FFR and OCT exam are used for different purposes during percutaneous coronary intervention (PCI). The FFR is a decision-making tool to determine if additional procedures are necessary, while the OCT exam is used to optimize the stent procedure. The use of both tests provides additional information to help perform a excellent procedure, but it is more expensive and time-consuming. Therefore, an OCT-derived machine learning FFR test may be helpful. Previous studies have demonstrated that OCT-based machine learning FFR before the procedure has shown good diagnostic performance in predicting FFR, irrespective of the coronary territory. Despite the rapid development of technologies and tools for PCI, a significant number of patients experienced adverse events, such as recurrence of angina and silent ischemia despite angiographically successful PCI. Suboptimal PCI is a well-known independent prognostic factor for major cardiovascular accidents. Therefore, measuring post-PCI FFR immediately after stent implantation is crucial to optimize the procedure outcome and improve the patient's prognosis. Although the importance of measuring post-PCI FFR is gradually emerging, there is currently no model for OCT-based machine learning FFR that predicts FFR after stent insertion. In patients who underwent percutaneous coronary intervention using stents for ischemic heart disease, we will compare the diagnostic accuracy of the fractional flow reserve (FFR) model derived by machine learning based on optical coherence tomography (OCT) exam after coronary artery stent implantation with the wire-based FFR. ;

Study Design

Related Conditions & MeSH terms

Fractional Flow Reserve, Myocardial
Tomography, Optical Coherence

Clinical Trial Details

NCT number	NCT06341361
Study type	Observational
Source	Yonsei University
Contact	Oh-Hyun Lee, MD
Phone	+82-31-5189-8786
Email	Decenthyun@yuhs.ac
Status	Not yet recruiting
Phase
Start date	April 15, 2024
Completion date	October 15, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05608902` - Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)
Completed	`NCT03497000` - Effects of OCTA-guided PDT in Acute CSC	N/A
Completed	`NCT03326908` - Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study	N/A
Recruiting	`NCT04591938` - FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study	N/A
Active, not recruiting	`NCT03040934` - Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)	N/A
Recruiting	`NCT05728216` - Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)
Completed	`NCT04443231` - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Completed	`NCT03268096` - Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination
Enrolling by invitation	`NCT06167642` - Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Completed	`NCT02454920` - Measurement of Insertion of Extraocular Muscles Using Anterior Segment Optical Coherence Tomography	N/A
Recruiting	`NCT06035783` - Calcium Reduction by Orbital Atherectomy in Western Europe
Enrolling by invitation	`NCT05692362` - Measure Airway Compliance by Endobronchial Optical Coherence Tomography
Recruiting	`NCT05663333` - Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)
Recruiting	`NCT03033810` - FFR Versus iFR in Assessment of Hemodynamic Lesion Significance	N/A
Completed	`NCT03460600` - Vitreo-papillary Traction as an Entity Identified by Optical Coherence Tomography (OCT).	N/A
Completed	`NCT05635136` - Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Kidney Transplant Recipients (HARBOR)
Completed	`NCT03180931` - Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis	N/A
Recruiting	`NCT04683133` - The FAST OCT Study	N/A
Completed	`NCT03257020` - The Diagnostic Performance of BMO-MRW and RNFL Thickness and Their Combinational Index Using Artificial Neural Network	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.